Health

Zeus Launches Next-Generation Tubing for Bioresorbable Vascular Scaffolds

The New Absorv™ XSE Features Expanded Sizes, Improved Uniformity, and Customizable Properties ORANGEBURG, S.C., Sept. 27, 2023 /PRNewswire/ -- Zeus, a global leader in advanced polymer solutions, announced today that it has developed Absorv™ XSE oriented tubing, the newest member of the company'...

2023-09-27 20:00 1516

Hong Kong Breast Cancer Registry Report No. 15 Press Conference: Mammogram Screening Saves Lives, Saves Treatment Cost

HONG KONG, Sept. 27, 2023 /PRNewswire/ -- The Hong Kong Breast Cancer Registry (HKBCR), run by the Hong Kong Breast Cancer Foundation Limited (HKBCF), published its 15th annual research report at a press conference today. The Report aims to bring a better understanding of the clinical and economi...

2023-09-27 17:28 2009

The Excitement Returns as AIA Carnival Kicks Off Sales and Promotions for this Winter's Greatest Event!

HONG KONG, Sept. 27, 2023 /PRNewswire/ -- The AIA Carnival, Hong Kong's award winning annual winter festival event title sponsored by AIA Hong Kong ("AIA"), makes its long-awaited return on21 December 2023 and will run every day until 25 February 2024 at the Central Harbourfront Event Space. <...

2023-09-27 16:23 1968

Besins Healthcare Unveils State-of-the-Art Hormone Factory in Muel, Spain, Amplifying Global Production Capabilities by 30%

"A Milestone in European Pharmaceutical Manufacturing": Besins Healthcare Debuts Pioneering Plant to Address Soaring Global Demand for Hormones and to Fortify Europe's Medical Sovereignty MONACO, Sept. 27, 2023 /PRNewswire/ -- Besins Healthcare, a global lead in Women's and Men's Reproductive He...

2023-09-27 15:56 1604

Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report

Rapid acceleration in IP creation and scientific knowledge drives growing acceptance of AI and ML in drug discovery and development United States and Mainland China continue to lead innovation and remain at the forefront of AI technology advancement for drug discovery LONDON, Sept. 27, 2023 /PRN...

2023-09-27 15:00 1700

HRH Princess Astrid of Belgium visits Telix's New European Manufacturing Facility in Brussels South

MELBOURNE, Australia and LIEGE, Belgium, Sept. 27, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) has welcomed Her Royal Highness,Princess Astrid, Princess of Belgium to Telix Manufacturing Solutions (TMS), the Company's recently inaugurated production facility,...

2023-09-27 12:00 2059

'Bayer For Her' Supporting 365 Days Conversations of Care to More Women in Asia

* Bridging the gap on lack of discussion amongst Asian women on their health concerns this World Contraception Day (WCD) SINGAPORE, Sept. 27, 2023 /PRNewswire/ -- Bayer Pharmaceuticals Division inAsia/Pacific announced today in conjunction with World Contraception Day, the inception of its 'Bay...

2023-09-27 10:00 2196

World's Deepest Mining Site Trusted Oizom's Real-Time Air Quality Monitors for Maintaining Occupational Health & Safety

AHMEDABAD, India, Sept. 27, 2023 /PRNewswire/ -- In a pivotal move to elevate occupational health, safety, and environmental standards, Oizom has successfully deployed its real-time air quality monitor - Dustroid - at the world's deepest gold undermineSouth Africa. Oizom is a leading global compa...

2023-09-27 10:00 2241

Remegen's Innovative New Drug Telitacicept(RC18) Obtains Positive Phase III Results, Submitted for Second Indication for Treatment of Rheumatoid Arthritis

YANTAI, China, Sept. 27, 2023 /PRNewswire/ -- RemeGen Co., Ltd.  ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a fully-integrated commercial-stage biotechnology company, recently announced that Telitacicept(RC18) for injection obtained positive results in a Phas...

2023-09-27 09:30 3288

SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference

These are the first in a series of presentations scheduled through the end of the year sharing advances to SK Biopharmaceutical's targeted protein degradation (TPD) pipeline SEOUL, South Korea and KING OF PRUSSIA, Pa., Sept. 26, 2023 /PRNewswire/ -- SK Biopharmaceuticals, a global biotech focuse...

2023-09-27 08:30 1427

ABM Therapeutics' ABM-1310 Granted Fast Track Designation by the FDA Following Orphan Drug Designation

SAN DIEGO and SHANGHAI, Sept. 26, 2023 /PRNewswire/ -- ABM Therapeutics is pleased to announce today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for the investigation of ABM-1310 for the treatment of Glioblastoma (GBM) patients carrying BRAF V600E mutation,...

2023-09-27 00:00 1700

Latest Updates of Viva's Portfolio Companies

HONG KONG, Sept. 26, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the su...

2023-09-26 21:06 1737

China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering

HANGZHOU, China, Sept. 26, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it ...

2023-09-26 21:00 3253

Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business update

Highlights Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design and trial endpoints. UK sites added to the XanaCIDD trial of cognitive impairment associated with depression, due to report resu...

2023-09-26 20:51 1429

YS Biopharma Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine

GAITHERSBURG, Md., Sept. 26, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...

2023-09-26 20:30 1538

World Contraception Day 2023: Bayer Indonesia launches "Bayer For Her" to improve the reproductive health of Indonesian women

Bayer promotes the empowerment of Indonesian women, enabling them to make informed choices on their reproductive health to enhance a better quality of life. JAKARTA, Indonesia, Sept. 26, 2023 /PRNewswire/ -- Coinciding with the commemoration of World Contraception Day 2023, Bayer Indonesia launc...

2023-09-26 16:56 2121

WuXi Vaccines Launches Its First Vaccines CDMO Site in China

SUZHOU, China, Sept. 26, 2023 /PRNewswire/ -- WuXi Vaccines, a leading contract development and manufacturing organization (CDMO) focused on vaccine discovery, development, and manufacturing, has launched its first standalone vaccines CDMO site in Suzhou,China. The opening will add drug substanc...

2023-09-26 15:41 1444

LONGi reduces the number of people lacking electricity and facilitates energy equity to keep the world with disparities in harmony empowered by light

GENEVA, Sept. 26, 2023 /PRNewswire/ -- Lebanon faces an acute shortage of electricity, and consequently private generators have become a ubiquitous presence on the streets of the country since the 1990s. AL Zaharaa Hospital, one of the largest hospitals inLebanon, is a comprehensive hospital inte...

2023-09-26 14:49 1631

Ascletis Announces Completion of Enrollment of 120 Patients in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma

--Based on prespecified interim analysis condition, 120 patients are likely to lead sufficient events for interim analysis of progression-free survival (PFS) HANGZHOU and SHAOXING, China, Sept. 26, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces the completion o...

2023-09-26 08:10 2037

Recommended Souvenir from Korea, Jung Kwan Jang Red Ginseng

SEOUL, South Korea, Sept. 26, 2023 /PRNewswire/ -- KGC(Korea Ginseng Corp.) promotes newly launched "Korean Red Ginseng Extract Everytime Film" as the most recommended souvenir from Korea. A high volume of sales with 130,000 units were sold within a mere month of its launch this summer due to its...

2023-09-26 08:00 4492
1 ... 160161162163164165166 ... 847